Korro Bio Inc (KRRO)

May 23, 2026

Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come - Bez Kabli

May 23, 2026

May 21, 2026

Korro Bio Inc. (KRRO) Surges Nearly 12% as Biotech Momentum BuildsExpert Momentum Signals - Newser

May 21, 2026

May 19, 2026

Korro Bio Selects KRRO-111 as RNA Editing Therapy Candidate for Alpha-1 Antitrypsin Deficiency (AATD) with Best-in-Class Preclinical Results 1 - Minichart

May 19, 2026

May 19, 2026

Korro Bio, Inc.Common Stock (NQ: KRRO - The Chronicle-Journal

May 19, 2026

May 19, 2026

Korro Bio adds AATD treatment candidate to pipeline By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

H.C. Wainwright cuts Korro Bio stock price target on financing impact By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

Korro Bio nominates new candidate for AATD - BioWorld News

May 19, 2026

May 19, 2026

H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Cuts Target Price to $15 - Moomoo

May 19, 2026

May 19, 2026

Korro Bio, Inc. selects KRRO-111 after preclinical success in repairing AAT protein - Traders Union

May 19, 2026

May 19, 2026

H.C. Wainwright cuts Korro Bio stock price target on financing impact - Investing.com Nigeria

May 19, 2026

May 19, 2026

Korro Bio Advances KRRO-111 for Alpha-1 Deficiency - TipRanks

May 19, 2026

May 19, 2026

Korro Bio adds AATD treatment candidate to pipeline - Investing.com

May 19, 2026

May 19, 2026

Citigroup initiates coverage of Korro Bio (KRRO) with buy recommendation - MSN

May 19, 2026

May 18, 2026

KRRO Initiates Coverage by Citigroup -- Announces Buy Rating - GuruFocus

May 18, 2026

May 18, 2026

Citi Initiates Korro Bio(KRRO.US) With Buy Rating, Announces Target Price $21 - Moomoo

May 18, 2026

May 18, 2026

Lynx1 Capital Management LP's Korro Bio Inc(KRRO) Holding History - GuruFocus

May 18, 2026

May 18, 2026

Citigroup Initiates Korro Bio at Buy With $21 Price Target - marketscreener.com

May 18, 2026

May 15, 2026

Should You Sell Korro Bio (KRRO) After -8.12% Drop? 2026-05-15Stock Picks - Newser

May 15, 2026

May 15, 2026

Korro Bio, Inc. advances KRRO-121 RNA editing therapy for hyperammonemia toward clinical stage - Traders Union

May 15, 2026

May 15, 2026

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 15, 2026

May 15, 2026

New Korro Bio hire gets option for 3,000 shares at $11.20 - Stock Titan

May 15, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 13, 2026

Korro Bio (KRRO) Price Target Decreased by 30.76% to 66.30 - MSN

May 13, 2026

May 11, 2026

Korro announces oversubscribed $85 million private placement - MSN

May 11, 2026

May 10, 2026

Number of shareholders of Korro Bio, Inc. – NASDAQ:KRRO - TradingView

May 10, 2026

May 09, 2026

Korro Bio (NASDAQ:KRRO) Announces Quarterly Earnings Results - MarketBeat

May 09, 2026

May 08, 2026

Wave Life Sciences (WVE) Attracts Positive Attention Amid Compet - GuruFocus

May 08, 2026

May 08, 2026

JonesTrading Upgrades Korro Bio(KRRO.US) to Buy Rating, Announces Target Price $23 - Moomoo

May 08, 2026

May 08, 2026

Jones Trading upgrades Korro Bio stock rating on AATD program potential By Investing.com - Investing.com South Africa

May 08, 2026

May 08, 2026

Jones Trading upgrades Korro Bio stock rating on AATD program potential - Investing.com Nigeria

May 08, 2026

May 08, 2026

Chardan Capital Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo

May 08, 2026

May 07, 2026

Korro Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2026

May 07, 2026

Korro Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

Korro Bio IncReports No Collaboration Reve - Moomoo

May 07, 2026

May 07, 2026

Korro Bio (KRRO) trims R&D spend and boosts cash to $157M - Stock Titan

May 07, 2026

May 07, 2026

Korro Bio, Inc. 1Q 2026: Revenue $0M, EPS $(1.69) — 10-Q Summary - TradingView

May 07, 2026

May 07, 2026

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

May 07, 2026

May 07, 2026

Korro raises $85M, targets 2026 filing for rare-disease drug - Stock Titan

May 07, 2026

May 07, 2026

Korro Bio (Nasdaq: KRRO) boosts cash to $157M and targets 2026 KRRO-121 filing - Stock Titan

May 07, 2026

May 06, 2026

What Korro Bio (KRRO) management is not saying enough about (Technical Strength) 2026-05-06Top Trending Breakouts - newser.com

May 06, 2026

May 05, 2026

Korro CEO and top executives line up two investor fireside chats - Stock Titan

May 05, 2026

May 05, 2026

Korro to Participate in Upcoming Investor Conferences - marketscreener.com

May 05, 2026

May 05, 2026

Korro Bio executives to present at two major investor conferences in May 2026 - Pluang

May 05, 2026

May 01, 2026

Korro Bio Inc expected to post a loss of $1.84 a shareEarnings Preview - TradingView

May 01, 2026

Apr 30, 2026

What makes Korro Bio, Inc. (KRRO) a new buy stock - MSN

Apr 30, 2026

Apr 29, 2026

Korro Bio (KRRO) to Release Quarterly Earnings on Wednesday - MarketBeat

Apr 29, 2026

Apr 28, 2026

What Makes Korro Bio, Inc. (KRRO) a New Buy Stock - Yahoo Finance Australia

Apr 28, 2026